Moreover, compound 8 is a potent SIRT2 inhibitor and can effectively inhibit the growth, invasion and migration of non-small cell lung cancer (NSCLC) cells, providing more references and options for the research of SIRT2 targeted cancer treatment.30 The gene discussed is SIRT2; the disease is non-small cell lung carcinoma.